Quantcast Alnylam Pharmaceut Stock Quote | Stock Price for ALNY | Financial News | myMotherLode.com

Financial News

Motherlode Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Alnylam Pharmaceut (NQ: ALNY)
76.69 USD  +2.31 (+3.11%)
Official Closing Price  /  Updated: 6:08 PM EST, Dec 10, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 800,800
Open 74.75
Bid (Size) 65.00 (1)
Ask (Size) 96.00 (1)
Prev. Close 74.38
Today's Range 74.43 - 78.03
52wk Range 63.57 - 153.99
Shares Outstanding 100,522,411
Dividend Yield N/A
Performance
YTD
-41.84%
-41.84%
1 Month
+12.91%
+12.91%
3 Month
-26.44%
-26.44%
6 Month
-23.35%
-23.35%
1 Year
-40.18%
-40.18%
Top News
More News
Recent Analysis Shows Microsoft, Alnylam Pharmaceuticals, F5 Networks, Green Plains Partners LP, Itron, and Progress Software Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Microsoft Corporation... Read More
from GlobeNewswire News Releases
Alnylam Provides R&D Updates and Announces 2019 Product and Pipeline Goals at R&D Day
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announces it is hosting its R&D Day in New York City today. During the event, the Company plans to discuss its... Read More
from Business Wire News Releases
More News
Read More
Alnylam to Webcast R&D Day
from Business Wire News Releases
Alnylam Announces Settlement of Litigation with Silence Therapeutics
from Business Wire News Releases
Brii Biosciences Builds Innovative Pipeline, Forges Public-Private Partnerships to Bring Novel Medicines to Chinese Patients
from Business Wire News Releases
DEADLINE TOMORROW: The Schall Law Firm Announces it is Investigating Claims Against Alnylam Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
from GlobeNewswire News Releases
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TGTX, ALNY, CHGG, CWH and DY
from GlobeNewswire News Releases
ALNY NOV 26 DEADLINE: Rosen Law Firm Reminds Alnylam Pharmaceuticals, Inc. Investors of Important Deadline in Class Action
from GlobeNewswire News Releases
MONDAY DEADLINE: Kaskela Law LLC Announces Class Action Lawsuit Against Alnylam Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm – ALNY
from GlobeNewswire News Releases
IWF's Holdings Could Mean 19% Gain Potential
category ETFs
from ETF Channel
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Alnylam Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Follow myMotherLode.com at these social networks Make Us Your Homepage Today Follow us on Facebook Follow us on Twitter Follow us on Youtube Follow us on LinkedIn Follow our RSS Feed
Yellow Pages

Popular Searches

Local Radio Stations
© Copyright 2000-2017 Clarke Broadcasting Corporation. All rights reserved.